RevealDx Secures $3.4 Million in Latest Strategic Investment Funding Round

RevealDx secured $3.4 million in its latest Strategic Investment, adding another data point to the Healthcare & Life Sciences funding market.

RevealDx Raises $3.4 million in Funding

RevealDx secured a $3.4M strategic investment from 4DMedical alongside a global distribution agreement for RevealAI-Lung.

Investors Behind the Funding

The round was backed by 4DMedical. Capvizr tracks this investor activity alongside sector momentum, co-investor patterns, and recent comparable raises.

Company Profile and Market Context

RevealDx operates in Healthcare & Life Sciences. Medical imaging AI is consolidating via strategic investor-distributor deals rather than pure venture rounds. RevealAI-Lung scores lung nodules with a Malignancy Similarity Index inside existing PACS workflows. Regulatory clearance across three continents de-risks the distribution push.

Strategic Use of Funds

Expand access to RevealAI-Lung across the US, Europe, Australia and New Zealand

Looking Ahead

FDA clearance in the US, CE marking in Europe, and TGA approval in Australia.

Source reference: original announcement/article.